Skip to Main Content

Author Details

Grace Hyun J Kim
University of California los angeles
2014
37
17
PMIDPaper TitleJournal TitlePublished Year
36254789Multi-scale, domain knowledge-guided attention + random forest: a two-stage deep learning-based multi-scale guided attention models to diagnose idiopathic pulmonary fibrosis from computed tomography images.Med Phys2023
34751786Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenib.Neuro Oncol2022
37745675Sex differences in clinical outcomes and biological profiles in systemic sclerosis-associated interstitial lung disease: a post-hoc analysis of two randomised controlled trials.Lancet Rheumatol2022
33277978Racial Disparities in Systemic Sclerosis: Short- and Long-Term Outcomes Among African American Participants of SLS I and II.ACR Open Rheumatol2021
33547645End-to-end domain knowledge-assisted automatic diagnosis of idiopathic pulmonary fibrosis (IPF) using computed tomography (CT).Med Phys2021
33538094Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung Disease.Arthritis Rheumatol2021
33706419Reproducibility of lung nodule radiomic features: Multivariable and univariable investigations that account for interactions between CT acquisition and reconstruction parameters.Med Phys2021
33781141The value of imaging and clinical outcomes in a phase II clinical trial of a lysophosphatidic acid receptor antagonist in idiopathic pulmonary fibrosis.Ther Adv Respir Dis2021
33753286A study design for statistical learning technique to predict radiological progression with an application of idiopathic pulmonary fibrosis using chest CT images.Contemp Clin Trials2021
34703964Genicular Artery Embolization for the Treatment of Symptomatic Knee Osteoarthritis.JB JS Open Access2021
34309040Evaluating Size-Specific Dose Estimate (SSDE) as an estimate of organ doses from routine CT exams derived from Monte Carlo simulations.Med Phys2021
31451973Prediction of idiopathic pulmonary fibrosis progression using early quantitative changes on CT imaging for a short term of clinical 18-24-month follow-ups.Eur Radiol2020
31728683Correction to: Toward clinically usable CAD for lung cancer screening with computed tomography.Eur Radiol2020
33088361Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis.Open Respir Med J2020
32859976When are results of single-arm studies dramatic?Nat Rev Clin Oncol2020
32906032The MUC5B promoter variant does not predict progression of interstitial lung disease in systemic sclerosis.Semin Arthritis Rheum2020
32866440Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet Respir Med2020
32432411Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient-Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II.ACR Open Rheumatol2020
31430058Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease.Arthritis Rheumatol2020
30677145Technical Note: Design and implementation of a high-throughput pipeline for reconstruction and quantitative analysis of CT image data.Med Phys2019
35382149Determining progression of scleroderma-related interstitial lung disease.J Scleroderma Relat Disord2019
29986154Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis.Am J Respir Crit Care Med2019
30770517Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II.J Rheumatol2019
29340285Quantitative bone scan lesion area as an early surrogate outcome measure indicative of overall survival in metastatic prostate cancer.J Med Imaging (Bellingham)2018
30265153Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II.Ann Am Thorac Soc2018
29728744Free-breathing quantification of hepatic fat in healthy children and children with nonalcoholic fatty liver disease using a multi-echo 3-D stack-of-radial MRI technique.Pediatr Radiol2018
29506902Comparison of Double-Freeze versus Modified Triple-Freeze Pulmonary Cryoablation and Hemorrhage Volume Using Different Probe Sizes in an In Vivo Porcine Lung.J Vasc Interv Radiol2018
29099620Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II).Am J Respir Crit Care Med2018
28012804Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II.Chest2017
28112399Estimating organ doses from tube current modulated CT examinations using a generalized linear model.Med Phys2017
28376288Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II.Arthritis Rheumatol2017
28122122The effect of radiation dose reduction on computer-aided detection (CAD) performance in a low-dose lung cancer screening population.Med Phys2017
28685929Erratum: "Estimating organ doses from tube current modulated CT examinations using a generalized linear model" [Med. Phys. Vol 44 (4), 1500-1513 (2017)].Med Phys2017
27469583Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.Lancet Respir Med2016
25749178Determining the Variability of Lesion Size Measurements from CT Patient Data Sets Acquired under "No Change" Conditions.Transl Oncol2015
26704522Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials.Arthritis Res Ther2015
25052078Toward clinically usable CAD for lung cancer screening with computed tomography.Eur Radiol2014
  • 1 - 37 of 37

Recommended Authors

Massachusetts General Hospital and the Harvard Medical School
Career Start Year 2018
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2018
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2017
Number of shared co-authors 0
University of California Los Angeles
Career Start Year 2017
Number of shared co-authors 6
University of California los angeles
Career Start Year 2015
Number of shared co-authors 6
Massachusetts General Hospital and Harvard Medical School
Career Start Year 2013
Number of shared co-authors 0
the First Affiliated Hospital of Guangzhou Medical University
Career Start Year 2012
Number of shared co-authors 0
University of California los angeles
Career Start Year 2012
Number of shared co-authors 3
Erasmus MC Cancer Institute, Erasmus University Medical Center
Career Start Year 2012
Number of shared co-authors 0
Center for Global Health, Perelman School of Medicine, University of Pennsylvania
Career Start Year 2012
Number of shared co-authors 2
Clinical Center, National Institutes of Health
Career Start Year 2009
Number of shared co-authors 0
University of California San Francisco
Career Start Year 2008
Number of shared co-authors 0
Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital
Career Start Year 2007
Number of shared co-authors 7
Massachusetts General Hospital, USA Harvard Medical School
Career Start Year 2005
Number of shared co-authors 0
University of California san francisco
Career Start Year 2005
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 0
The First Affiliated Hospital of Guangzhou Medical University
Career Start Year 2003
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1999
Number of shared co-authors 0
Harvard Medical School
Career Start Year 1999
Number of shared co-authors 2
Maastricht University Medical Centre
Career Start Year 1998
Number of shared co-authors 0
MS Technologies Corporation
Career Start Year 1998
Number of shared co-authors 0
Viatris Inc.
Career Start Year 1997
Number of shared co-authors 0
Radboud University Medical Center
Career Start Year 1997
Number of shared co-authors 4
Siemens Healthineers
Career Start Year 1991
Number of shared co-authors 0
Rocky Mountain Regional VA Medical Center, CO University of Colorado
Career Start Year 1989
Number of shared co-authors 1
Clinical Center, National Institutes of Health
Career Start Year 1989
Number of shared co-authors 0
Brigham and Women's Hospital
Career Start Year 1986
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 1984
Number of shared co-authors 3
Stanford University.
Career Start Year 1981
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 1979
Number of shared co-authors 3

Collaborators

David Geffen School of Medicine at university of california los angeles
Co-authored papers 26
University of California los angeles
Co-authored papers 10
University of California los angeles
Co-authored papers 10
David Geffen School of Medicine, University of California los angeles
Co-authored papers 6
David Geffen School of Medicine at University of California los angeles
Co-authored papers 4
David Geffen School of Medicine at university of california los angeles
Co-authored papers 2
University of California los angeles
Co-authored papers 2
David Geffen School of Medicine, University of California los angeles
Co-authored papers 2
David Geffen School of Medicine, University of California los angeles
Co-authored papers 2
David Geffen School of Medicine at university of california los angeles
Co-authored papers 2
Co-authored papers 2
University of California los angeles
Co-authored papers 2
American Medical Informatics Association, IEEE, Johns Hopkins University, Radiological Society of North America, University of California Los Angeles, University of California, Los Angeles
Co-authored papers 2
University of Texas McGovern Medical School
Co-authored papers 2
David Geffen School of Medicine, University of California los angeles
Co-authored papers 2
David Geffen School of Medicine at university of california los angeles
Co-authored papers 2
Co-authored papers 1
Bowdoin College
Co-authored papers 1
David Geffen School of Medicine at university of california los angeles
Co-authored papers 1
University of California Los Angeles (university of california los angeles)
Co-authored papers 1
Yale School of Medicine
Co-authored papers 1
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 1
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 1
University of Utah School of Medicine
Co-authored papers 1
university of california los angeles
Co-authored papers 1
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 1
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 1
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 1